The stability of three batches of purified Vero cell-derived, inactivated Japanese encephalitis vaccines was evaluated under various conditions. Vaccine products were stored separately at 2 to 8 ℃ and 37 ℃. At various times, vaccines samples were taken and evaluated for appearance, pH, residual aluminum, titer, and the results were compared with corresponding data of release tests. All three batches of vaccine products were conforming to release test standards, with residual host DNA being less than 100pg/dose, residual protein being 23.5ng/ml, and residual bovine albumin being 8.9ng/dose, respectively.
Introduction
Japanese encephalitis (JE) is an infectious disease caused by Arbovirus and transmitted by mosquitos [1] . JE presents as a seasonal epidemic disease mainly occurring in Asia. It was spread to Australia in 1995, and in recent years, the epidemic region covers 24 countries in Asia and Pacific region, which represents about 60% of world population (approximately 3 billion) [2, 3] . JE was firstly reported in China in 1951, and since then, China has been one of the countries severely affected by JE. Available data indicate that new JE cases in China represent 50% of global occurrence [4] . In fact, the actual case number may be 2-to 3-fold of published data [5] .
Two major JE vaccines currently marketed in China are SA14-14-2 attenuated JE vaccine and Vero cell-derived inactivated JE vaccine (VIJEV), both of which show good safety and potency [1] . However, the inactivated vaccines currently available produce severe side effect of fever. Given aluminum adjuvant can efficiently reduce side effect of fever following immunization, it is considered a supplementary product to currently marketed JE vaccines.
The stability of biologicals is directly related with their safety and potency. For vaccines, studying on their stability can determine their expiration date before which the titer of vaccines should be maintained acceptable. Common methods for studying the safety of biologicals include appearance, pH, titer, purity, etc [6] . Accelerated safety test has been widely used to study the safety of biologicals. This study evaluated the stability of three batches of purified VIJEV under various conditions.
Materials and Methods

Preparation of purified VIJEV
The virus used in this study was JE P3 demand. Inactivated JE vaccine manu--factured by Novaris has been approved to be used for populations above 2 month in the USA and European Union, which plays a supplementary role for current market [7] . Halstead [8, 9, 10] . After 4 weeks of storage, the titers of three batches of vaccines were still maintained above 95%, which is conforming to the requirement of WHO under this condition [11] . In reality, vaccines would not be exposed to high temperature. Even in case of high temperature, these vaccines would be This could be used as evidence for determining expiration.
Our study indicates VIJEV has excellent stability under various conditions within a specific duration of storage. However, cold chain transportation and storage should be maintained to ensure stability.
